US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

CDXS

Codexis (CDXS)

Codexis Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CDXS

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/14	22 : 11	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:CDXS	Codexis Inc
2024/05/14	19 : 52	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CDXS	Codexis Inc
2024/05/14	19 : 00	GlobeNewswire Inc.	Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting	NASDAQ:CDXS	Codexis Inc
2024/05/03	05 : 05	GlobeNewswire Inc.	Codexis Reports First Quarter 2024 Financial Results	NASDAQ:CDXS	Codexis Inc
2024/04/19	05 : 05	GlobeNewswire Inc.	Codexis to Report First Quarter 2024 Financial Results on May 2	NASDAQ:CDXS	Codexis Inc
2024/04/11	20 : 05	GlobeNewswire Inc.	Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board	NASDAQ:CDXS	Codexis Inc
2024/03/07	06 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CDXS	Codexis Inc
2024/02/29	06 : 05	GlobeNewswire Inc.	Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results	NASDAQ:CDXS	Codexis Inc
2024/02/28	02 : 15	AllPennyStocks.com	Biotech Rallied Strongly On Exclusive Licensing Agreement	NASDAQ:CDXS	Codexis Inc
2024/02/27	06 : 05	GlobeNewswire Inc.	Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche	NASDAQ:CDXS	Codexis Inc
2024/02/26	22 : 05	GlobeNewswire Inc.	Codexis to Participate in TD Cowen 44th Annual Health Care Conference	NASDAQ:CDXS	Codexis Inc
2024/02/20	22 : 05	GlobeNewswire Inc.	Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board	NASDAQ:CDXS	Codexis Inc
2024/02/17	06 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CDXS	Codexis Inc
2024/02/15	06 : 51	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:CDXS	Codexis Inc
2024/02/15	06 : 05	GlobeNewswire Inc.	Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28	NASDAQ:CDXS	Codexis Inc
2024/02/14	06 : 19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CDXS	Codexis Inc
2024/02/14	06 : 05	GlobeNewswire Inc.	Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key Milestones	NASDAQ:CDXS	Codexis Inc
2024/02/10	06 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CDXS	Codexis Inc
2024/02/02	06 : 05	GlobeNewswire Inc.	seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General Meeting	NASDAQ:CDXS	Codexis Inc
2024/01/25	04 : 27	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:CDXS	Codexis Inc
2024/01/09	22 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CDXS	Codexis Inc
2024/01/03	11 : 24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CDXS	Codexis Inc
2024/01/03	11 : 24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CDXS	Codexis Inc
2024/01/03	11 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CDXS	Codexis Inc
2024/01/03	11 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CDXS	Codexis Inc
2023/12/27	22 : 30	GlobeNewswire Inc.	Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108	NASDAQ:CDXS	Codexis Inc
2023/12/27	22 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CDXS	Codexis Inc
2023/12/14	06 : 06	GlobeNewswire Inc.	Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase	NASDAQ:CDXS	Codexis Inc
2023/12/14	06 : 05	GlobeNewswire Inc.	Codexis Announces Achievement of Gram-scale Synthesis with its ECO Synthesis™ Platform	NASDAQ:CDXS	Codexis Inc
2023/12/11	21 : 05	GlobeNewswire Inc.	Codexis KOL Event Highlights Significant Need for an Enzymatic Route of Synthesis in RNAi Therapeutics Manufacturing	NASDAQ:CDXS	Codexis Inc

Showing the most relevant articles for your search:NASDAQ:CDXS

1 2 3 4 5 6 7 8 9 10 次へ >>

Teleperformance (PK)

S&P International Divide...

BNP Paribas Issuance

BNP Paribas Issuance

Global Blockchain Acquis...

Delta Lloyd Invest

Zion Oil and Gas

Hartford Financial Servi...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約